N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

349

HTML

2551

Tables (1-6)

208

Sum=3108

Jun 21, 2006 (publication date) through Dec 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jun 21, 2006; 12(23): 3751-3755
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3751

Table 1 Indications for ERCP in N-acetylcysteine treated group (ACC-group) and control group

Citation: Milewski J, Rydzewska G, Degowska M, Kierzkiewicz M, Rydzewski A. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. World J Gastroenterol 2006; 12(23): 3751-3755
URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3751.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i23.3751